Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
about
Neuro-Ophthalmological EmergenciesGiant cell arteritis: a review.Ocular vascular occlusive disorders: natural history of visual outcome.Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.The treatment of giant cell arteritisReview of Giant cell arteritisManagement of ischemic optic neuropathies.Acute retinal arterial occlusive disordersCentral nervous system vasculitis: still more questions than answers.Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohortGiant cell arteritis: Current treatment and management.Retrobulbar blood flow and visual organ function disturbance in the course of giant cell arteritis coexisting with optic disc drusen - a case report.Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009).The diagnosis and treatment of giant cell arteritis.Clinical approach to optic neuropathies.Current understanding and management of giant cell arteritis and polymyalgia rheumatica.Clinical features of polymyalgia rheumatica and giant cell arteritis.Preserved Visual Acuity in Anterior Ischemic Optic Neuropathy Secondary to Giant Cell (temporal) Arteritis.Visual loss and other cranial ischaemic complications in giant cell arteritis.Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell ArteritisIdentification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases.Controlled dexamethasone delivery via double-walled microspheres to enhance long-term adipose tissue retention.Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis.The therapeutic test: an ancient malady in the 21st century.The Treatment of Giant Cell Arteritis.Three cases of neuroborreliosis misdiagnosed as giant cell arteritis
P2860
Q26783463-E032EE1F-5793-4E83-AC78-613B353B9C4DQ33688189-20F61D09-387D-437F-A2E7-392D6387A176Q33814379-89C7DBB0-34DE-4B9D-9568-653FA1479769Q34205665-ECE4E09A-D185-42D4-8DE8-7175401910C8Q34366371-6B7418C9-B178-4256-9E31-2B9F21329BBFQ34461224-60F54E98-912B-4094-91CF-46E176FDA3BAQ35040621-5C90BCF4-86D9-4FB5-A189-228875E11892Q35049587-38F6C015-F3C5-4A8A-A443-2CA4F75E6E9AQ35109284-A16AD634-B8CD-4143-B5E5-0E1735CA9881Q35151866-3555D9BF-61B3-4F59-A30B-BC10C40A0B88Q35200098-D40A6CA1-96D2-424F-9198-04FAE6B6008BQ35746677-F1EF1F2E-4A66-4F20-9F67-DD26C31307B3Q35870223-58D1A268-50A3-4586-85D4-B11113D7BBA6Q35891153-3181C2A1-A96F-46E7-8CF5-BA4AECBE2947Q36921249-92570F64-9665-4DEA-83A4-CF86C93A3317Q37239284-830694DD-EDE1-4208-9A3B-43D559CB858AQ37803414-D3F80E6F-8CC4-49AE-B9D2-1277B1AADD91Q38028863-E4EDF852-861C-4756-A491-B4EEE744C379Q38586589-845DE764-2609-4EEE-AF18-491C56EE7B12Q39416333-32B2CA96-A663-4FE9-A340-9FA46A0B8919Q39686214-06FD1AA7-C4CD-4778-A315-7E0176BC7065Q39918063-49DB540C-9535-4C2E-B20C-C6568965A194Q41156625-651581EE-8413-4FA5-8284-65B5B64F05E3Q42375628-578B0150-43C7-4DF2-8350-B4B5E9383DDBQ43035849-7DDC6313-D26E-4AD8-A8B6-4FA9E469D555Q44668587-B3D53803-4930-42DF-82A8-0EFCF017F41FQ51161072-11818A54-BCE8-4277-9230-790086D50C51Q58190165-27D00729-39EB-4286-932B-A42466719B78
P2860
Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Visual deterioration in giant ...... ses of corticosteroid therapy.
@ast
Visual deterioration in giant ...... ses of corticosteroid therapy.
@en
type
label
Visual deterioration in giant ...... ses of corticosteroid therapy.
@ast
Visual deterioration in giant ...... ses of corticosteroid therapy.
@en
prefLabel
Visual deterioration in giant ...... ses of corticosteroid therapy.
@ast
Visual deterioration in giant ...... ses of corticosteroid therapy.
@en
P1433
P1476
Visual deterioration in giant ...... ses of corticosteroid therapy.
@en
P2093
Bridget Zimmerman
Sohan Singh Hayreh
P304
P356
10.1016/S0161-6420(03)00228-8
P577
2003-06-01T00:00:00Z